Does short-term vitamin c reduce cardiovascular risk in type 2 diabetes?

Endocrine Practice

Volumn 19, Issue 5, 2013, Pages 785-791

  Gutierrez, Absalon D ^a   Duran Valdez, Elizabeth ^b   Robinson, Irina ^b   De Serna, Daniela G ^b   Schade, David S ^b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; ASCORBIC ACID; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN; INSULIN; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE MARKER; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERCOAGULABILITY; INFLAMMATION; INSULIN BLOOD LEVEL; LIPID BLOOD LEVEL; LOW DRUG DOSE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PLASMA HALF LIFE; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; TREATMENT DURATION; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

ADULT; ANTIOXIDANTS; ASCORBIC ACID; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INSULIN; MALE; MIDDLE AGED; OXIDATIVE STRESS; RISK FACTORS; TRIGLYCERIDES;

EID: 84886934195     PISSN: 1530891X     EISSN: 19342403     Source Type: Journal    
DOI: 10.4158/EP12431.OR     Document Type: Article

References (39)

1. Frei B, England L, Ames BN. Ascorbate is an outstanding antioxidant in human blood plasma. Proc Natl Acad Sci U S A. 1989;86:6377-6381.
2. Bruno RS, Leonard SW, Atkinson J, et al. Faster plasma vitamin E disappearance in smokers is normalized by vitamin C SUPPL.ementation. Free Radic Biol Med. 2006; 40:689-697.
3. Gokce N, Keaney JF Jr, Frei B, et al. Long-term ascorbic acid administration reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation. 1999; 99:3234-3240.
4. Pleiner J, Schaller G, Mittermayer F, et al. Intra-arterial vitamin C prevents endothelial dysfunction caused by ischemia-reperfusion. Atherosclerosis. 2008;197:383-391.
5. Vincent HK, Bourguignon CM, Weltman AL, et al. Effects of antioxidant SUPPL.ementation on insulin sensitivity, endothelial adhesion molecules, and oxidative stress in normal-weight and overweight young adults. Metabolism. 2009;58:254-262.
6. Davison GW, Ashton T, George L, et al. Molecular detection of exercise-induced free radicals following ascorbate prophylaxis in type 1 diabetes mellitus: A randomised controlled trial. Diabetologia. 2008;51:2049-2059.
7. Cook NR, Albert CM, Gaziano JM, et al. A randomized factorial trial of vitamins C and E and beta-carotene in the secondary prevention of cardiovascular events in women: Results from the Women's Antioxidant Cardiovascular Study. Arch Intern Med. 2007;167:1610-1608.
8. Collins R, Armitage J, Parish S, et al. Heart Protection Study. Lancet. 2003;361:529-530.
9. Hercberg S, Galan P, Preziosi P, et al. The SU.VI.MAX Study: A randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. Arch Intern Med. 2004; 164:2335-2342.
10. Lykkesfeldt J, Poulsen HE. Is vitamin C SUPPL.ementation beneficial? Lessons learned from randomized controlled trials. Br J Nutr. 2010;103:1251-1259.
11. Fang JC, Kinlay S, Beltrame J, et al. Effect of vitamins C and E on progression of transplant-associated arteriosclerosis: A randomised trial. Lancet. 2002;359:1108-1113.
12. Salonen JT, Nyyssönen K, Salonen R, et al. Antioxidant SUPPL.ementation in Atherosclerosis Prevention (ASAP) study: A randomized trial of the effect of vitamins E and C on 3-year progression of carotid atherosclerosis. J Intern Med. 2000;248: 377-386.
13. Salonen RM, Nyyssönen K, Kaikkonen J, et al. Six-year effect of combined vitamin C and E SUPPL.ementation on atherosclerotic progression: The Antioxidant SUPPL.ementation in Atherosclerosis Prevention (ASAP) Study. Circulation. 2003; 107:947-953.
14. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
15. Holvoet P, Vanhaecke J, Janssens S, Van de Werf F, Collen D. Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease. Circulation. 1998;98:1487-1494.
16. Elphick MC. Modified colorimetric ultramicro method for estimating Nefa in serum. J Clin Pathol. 1968;21:567-570.
17. Roberts WL, Moulton L, Law TC, et al. Evaluation of nine automated high-sensitivity C-reactive protein methods: Implications for clinical and epidemiological applications. Part. Clin Chem. 2001;47:418-425.
18. Suominen P. Evaluation of an enzyme immunometric assay to measure serum adiponectin concentrations. Clin Chem. 2004;50:219-221.
19. Moody MD, Van Arsdell SW, Murphy KP, Orencole SF, Burns C. Array-based ELISAs for high-throughput analysis of human cytokines. Biotechniques. 2001;31:186-90, 192-194.
20. Declerck PJ, Alessi MC, Verstreken M, Kruithof EK, Juhan-Vague I, Collen D. Measurement of plasminogen activator inhibitor 1 in biologic fluids with a murine monoclonal antibody-based enzyme-linked immunosorbent assay. Blood. 1988;71:220-225.
21. Geffken DF, Keating FG, Kennedy MH, Cornell ES, Bovill EG, Tracy RP. The measurement of fibrinogen in population-based research. studies on instrumentation and methodology. Arch Pathol Lab Med. 1994;118:1106-1109.
22. Bondar RJ, Mead DC. Evaluation of glucose-6-phosphate dehydrogenase from Leuconostoc mesenteroides in the hexokinase method for determining glucose in serum. Clin Chem. 1974;20:586-590.
23. Andersen L, Dinesen B, Jørgensen PN, Poulsen F, Røder ME. Enzyme immunoassay for intact human insulin in serum or plasma. Clin Chem. 1993;39:578-582.
24. Fossati P, Prencipe L. Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem. 1982;28:2077-2080.
25. Allain CC, Poon LS, Chan CS, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem. 1974;20:470-475.
26. SAS Institute Inc., SAS/STAT® 9.3 User's Guide. Cary, NC, USA: Copyright© 2011.
27. Graumlich JF, Ludden TM, Conry-Cantilena C, Cantilena LR Jr, Wang Y, Levine M. Pharmacokinetic model of ascorbic acid in healthy male volunteers during depletion and repletion. Pharm Res. 1997;14:1133-1139.
28. Levine M, Conry-Cantilena C, Wang Y, et al. Vitamin C pharmacokinetics in healthy volunteers: Evidence for a recommended dietary allowance. Proc Natl Acad Sci U S A. 1996;93:3704-3709.
29. Heitzer T, Schlinzig T, Krohn K, Meinertz T, Münzel T. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation. 2001;104:2673-2678.
30. Van Hoydonck PG, Schouten EG, Manuel-Y-Keenoy B, van Campenhout A, Hoppenbrouwers KP, Temme EH. Does vitamin C SUPPL.ementation influence the levels of circulating oxidized LDL, sICAM-1, sVCAM-1 and vWF-antigen in healthy male smokers? Eur J Clin Nutr. 2004; 58:1587-1593.
31. Tessier DM, Khalil A, Trottier L, Fülöp T. Effects of vitamin C SUPPL.ementation on antioxidants and lipid peroxidation markers in elderly subjects with type 2 diabetes. Arch Gerontol Geriatr. 2009;48:67-72.
32. Gutierrez AD, Gonzalez de Serna D, Robinson I, Schade DS. The response of gamma vitamin E to varying dosages of alpha vitamin E plus vitamin C. Metabolism. 2009;58: 469-478.
33. Ceriello A, Bortolotti N, Motz E, et al. Meal-generated oxidative stress in type 2 diabetic patients. Diabetes Care. 1998;21:1529-1533.
34. Nappo F, Esposito K, Cioffi M, et al. Postprandial endothelial activation in healthy subjects and in type 2 diabetic patients: Role of fat and carbohydrate meals. J Am Coll Cardiol. 2002;39:1145-1150.
35. Liu L, Meydani M. Combined vitamin C and E SUPPL.ementation retards early progression of arteriosclerosis in heart transplant patients. Nutr Rev. 2002;60:368-371.
36. Steinberg D, Witztum JL. Is the oxidative modification hypothesis relevant to human atherosclerosis? Do the antioxidant trials conducted to date refute the hypothesis? Circulation. 2002;105:2107-2111.
37. Sies H, Stahl W, Sevanian A. Nutritional, dietary and postprandial oxidative stress. J Nutr. 2005;135:969-972.
38. Williams MJ, Sutherland WH, McCormick MP, de Jong SA, Walker RJ, Wilkins GT. Impaired endothelial function following a meal rich in used cooking fat. J Am Coll Cardiol. 1999;33:1050-1055.
39. Ghanim H, Abuaysheh S, Sia CL, et al. Increase in plasma endotoxin concentrations and the expression of Toll-like receptors and suppression of cytokine signaling-3 in mononuclear cells after a high-fat, high-carbohydrate meal: Implications for insulin resistance. Diabetes Care. 2009;32:2281-2287.